Soft tissue sarcomas: Staging principles and prognostic nomograms

Journal of Surgical Oncology

Volumn 111, Issue 5, 2015, Pages 532-539

  Massarweh, Nader N ^a,b   Dickson, Paxton V ^c   Anaya, Daniel A ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

nomograms; prognostic factors; soft tissue sarcoma; staging

Indexed keywords

CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; METASTASIS; NOMOGRAM; PRIORITY JOURNAL; REVIEW; SOFT TISSUE SARCOMA; TUMOR LOCALIZATION; TUMOR VOLUME; PATHOLOGY; PROGNOSIS; SARCOMA;

HUMANS; NEOPLASM STAGING; NOMOGRAMS; PROGNOSIS; SARCOMA;

EID: 84925646734     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23851     Document Type: Review

References (44)

1. Manual for staging cancer. In:, Beahrs O, Hensen DE, Hunter RV, et al., editors. Manual for Staging of Cancer. Philadelphia: Lippincott; 1992. pp. 131-136.
2. Singer S, Corson JM, Demetri GD, et al.: Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995; 221: 185-195.
3. Maki RG, Moraco N, Antonescu CR, et al.: Toward better soft tissue sarcoma staging: Building on american joint committee on cancer staging systems versions 6 and 7. Ann Surg Oncol 2013; 20: 3377-3383.
4. Brennan MF, Antonescu CR, Moraco N, et al.: Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg 2014; 260: 416-422.
5. Ramanathan RC, A'Hern R, Fisher C, et al.: Modified staging system for extremity soft tissue sarcomas. Ann Surg Oncol 1999; 6: 57-69.
6. Lahat G, Tuvin D, Wei C, et al.: New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol 2008; 15: 2739-2748.
7. Mazeron JJ, Suit HD,: Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer 1987; 60: 1800-1808.
8. Fong Y, Coit DG, Woodruff JM, et al.: Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 1993; 217: 72-77.
9. Blazer DG III, Sabel MS, Sondak VK,: Is there a role for sentinel lymph node biopsy in the management of sarcoma? Surg Oncol 2003; 12: 201-206.
10. Riad S, Griffin AM, Liberman B, et al.: Lymph node metastasis in soft tissue sarcoma in an extremity. Clin Orthop Relat Res 2004; 129-134.
11. Schur S, Hoetzenecker K, Lamm W, et al.: Pulmonary metastasectomy for soft tissue sarcoma-report from a dual institution experience at the Medical University of Vienna. Eur J Cancer 2014; 50: 2289-2297.
12. Italiano A, Mathoulin-Pelissier S, Cesne AL, et al.: Trends in survival for patients with metastatic soft-tissue sarcoma. Cancer 2011; 117: 1049-1054.
13. Bell RS, O'Sullivan B, Liu FF, et al.: The surgical margin in soft-tissue sarcoma. J Bone Joint Surg Am 1989; 71: 370-375.
14. Coindre JM, Terrier P, Guillou L, et al.: Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: A study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001; 91: 1914-1926.
15. Gaynor JJ, Tan CC, Casper ES, et al.: Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: A study of 423 adults. J Clin Oncol 1992; 10: 1317-1329.
16. Heise HW, Myers MH, Russell WO, et al.: Recurrence-free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer 1986; 57: 172-177.
17. Markhede G, Angervall L, Stener B,: A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer 1982; 49: 1721-1733.
18. Pisters PW, Leung DH, Woodruff J, et al.: Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14: 1679-1689.
19. Zagars GK, Ballo MT, Pisters PW, et al.: Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: An analysis of 1225 patients. Cancer 2003; 97: 2530-2543.
20. Heslin MJ, Lewis JJ, Woodruff JM, et al.: Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol 1997; 4: 425-431.
21. Welker JA, Henshaw RM, Jelinek J, et al.: The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Cancer 2000; 89: 2677-2686.
22. Yao L, Nelson SD, Seeger LL, et al.: Primary musculoskeletal neoplasms: Effectiveness of core-needle biopsy. Radiology 1999; 212: 682-686.
23. Coindre JM,: Grading of soft tissue sarcomas: Review and update. Arch Pathol Lab Med 2006; 130: 1448-1453.
24. Trojani M, Contesso G, Coindre JM, et al.: Soft-tissue sarcomas of adults: Study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984; 33: 37-42.
25. The grading and staging of soft tissue sarcomas. In:, Fletcher C, editor. Pathology of Soft Tissue Sarcomas. Edinburgh, Scotland: Churchill Livingstone; 1990. pp. 221-238.
26. Guillou L, Coindre JM, Bonichon F, et al.: Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997; 15: 350-362.
27. Steyerberg EW, Vickers AJ, Cook NR, et al.: Assessing the performance of prediction models: A framework for traditional and novel measures. Epidemiology 2010; 21: 128-138.
28. Merkow RP, Hall BL, Cohen ME, et al.: Relevance of the c-statistic when evaluating risk-adjustment models in surgery. J Am Coll Surg 2012; 214: 822-830.
29. Harrell FE,: Regression modeling strategies: With applications to linear models, logistic regression, and survival analysis. New York: Springer 2001.
30. Anaya DA, Lahat G, Wang X, et al.: Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol 2010; 21: 397-402.
31. Ardoino I, Miceli R, Berselli M, et al.: Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma. Cancer 2010; 116: 2429-2436.
32. Cahlon O, Brennan MF, Jia X, et al.: A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Ann Surg 2012; 255: 343-347.
33. Canter RJ, Qin LX, Maki RG, et al.: A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clin Cancer Res 2008; 14: 8191-8197.
34. Dalal KM, Kattan MW, Antonescu CR, et al.: Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 2006; 244: 381-391.
35. Gronchi A, Miceli R, Shurell E, et al.: Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: Histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol 2013; 31: 1649-1655.
36. Kattan MW, Leung DH, Brennan MF,: Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002; 20: 791-796.
37. Zagars GK, Ballo MT, Pisters PW, et al.: Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: Analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57: 739-747.
38. Anaya DA, Lev DC, Pollock RE,: The role of surgical margin status in retroperitoneal sarcoma. J Surg Oncol 2008; 98: 607-610.
39. Stoeckle E, Coindre JM, Bonvalot S, et al.: Prognostic factors in retroperitoneal sarcoma: A multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001; 92: 359-368.
40. Blair SL, Lewis JJ, Leung D, et al.: Multifocal extremity sarcoma: An uncommon and controversial entity. Ann Surg Oncol 1998; 5: 37-40.
41. Anaya DA, Lahat G, Liu J, et al.: Multifocality in retroperitoneal sarcoma: A prognostic factor critical to surgical decision-making. Ann Surg 2009; 249: 137-142.
42. Conley AP, Trent J, Zhang W,: Recent progress in the genomics of soft tissue sarcomas. Curr Opin Oncol 2008; 20: 395-399.
43. Baird K, Davis S, Antonescu CR, et al.: Gene expression profiling of human sarcomas: Insights into sarcoma biology. Cancer Res 2005; 65: 9226-9235.
44. Kattan MW, Heller G, Brennan MF,: A competing-risks nomogram for sarcoma-specific death following local recurrence. Stat Med 2003; 22: 3515-3525.